Literature DB >> 1580817

Albendazole therapy for giant subarachnoid cysticerci.

O H Del Brutto1, J Sotelo, R Aguirre, E Díaz-Calderón, T A Alarcón.   

Abstract

Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580817     DOI: 10.1001/archneur.1992.00530290123021

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery.

Authors:  Jefferson V Proaño; Jaime Torres-Corzo; Roberto Rodríguez-Della Vecchia; Gabriel Guizar-Sahagun; Leonardo Rangel-Castilla
Journal:  Childs Nerv Syst       Date:  2009-06-26       Impact factor: 1.475

2.  Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.

Authors:  O H Del Brutto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

3.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

4.  High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis.

Authors:  D Callacondo; H H Garcia; I Gonzales; D Escalante; T E Nash
Journal:  Neurology       Date:  2012-04-18       Impact factor: 9.910

Review 5.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 6.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

7.  Transventricular neuroendoscopic excision of giant racemose subarachnoid cysticercosis.

Authors:  Carmina F Angeles; Dennis Vollmer; Aaron Mohanty
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 8.  Pharmacokinetic optimisation of the treatment of neurocysticercosis.

Authors:  J Sotelo; H Jung
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 9.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation.

Authors:  V Rajshekhar; G Chacko; R P Haran; M J Chandy; S M Chandi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.